ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 49 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$22,000
-66.7%
16,300
-50.8%
0.00%–
Q3 2019$66,000
-88.6%
33,100
-86.0%
0.00%
-100.0%
Q1 2019$578,000
+205.8%
236,982
+83.4%
0.00%–
Q4 2018$189,000–129,237–0.00%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders